These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Oritavancin - a new semisynthetic lipoglycopeptide agent to tackle the challenge of resistant gram positive pathogens. Das B; Sarkar C; Schachter J Pak J Pharm Sci; 2013 Sep; 26(5):1045-55. PubMed ID: 24035967 [TBL] [Abstract][Full Text] [Related]
23. Biosynthesis of glycopeptides: prospects for improved antibacterials. Donadio S; Sosio M Curr Top Med Chem; 2008; 8(8):654-66. PubMed ID: 18473890 [TBL] [Abstract][Full Text] [Related]
25. Characterization of the in vitro activity of novel lipoglycopeptide antibiotics. Arhin FF; Belley A; McKay GA; Moeck G Curr Protoc Microbiol; 2010 Feb; Chapter 17():Unit17.1. PubMed ID: 20131224 [TBL] [Abstract][Full Text] [Related]
26. Biosynthesis, biotechnological production, and application of teicoplanin: current state and perspectives. Jung HM; Jeya M; Kim SY; Moon HJ; Kumar Singh R; Zhang YW; Lee JK Appl Microbiol Biotechnol; 2009 Sep; 84(3):417-28. PubMed ID: 19609520 [TBL] [Abstract][Full Text] [Related]
35. Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin. Nailor MD; Sobel JD Infect Dis Clin North Am; 2009 Dec; 23(4):965-82, ix. PubMed ID: 19909893 [TBL] [Abstract][Full Text] [Related]
36. In vitro stepwise selection of reduced susceptibility to lipoglycopeptides in enterococci. Arhin FF; Seguin DL; Belley A; Moeck G Diagn Microbiol Infect Dis; 2017 Oct; 89(2):168-171. PubMed ID: 28733126 [TBL] [Abstract][Full Text] [Related]
37. In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptide. Lopez S; Hackbarth C; Romanò G; Trias J; Jabes D; Goldstein BP J Antimicrob Chemother; 2005 Mar; 55 Suppl 2():ii21-4. PubMed ID: 15750033 [TBL] [Abstract][Full Text] [Related]
38. Glycopeptides and glycodepsipeptides in clinical development: a comparative review of their antibacterial spectrum, pharmacokinetics and clinical efficacy. Van Bambeke F Curr Opin Investig Drugs; 2006 Aug; 7(8):740-9. PubMed ID: 16955686 [TBL] [Abstract][Full Text] [Related]
39. Regulation of teicoplanin biosynthesis: refining the roles of tei cluster-situated regulatory genes. Yushchuk O; Horbal L; Ostash B; Marinelli F; Wohlleben W; Stegmann E; Fedorenko V Appl Microbiol Biotechnol; 2019 May; 103(10):4089-4102. PubMed ID: 30937499 [TBL] [Abstract][Full Text] [Related]
40. Glycopeptide Antibiotic Resistance Genes: Distribution and Function in the Producer Actinomycetes. Yushchuk O; Binda E; Marinelli F Front Microbiol; 2020; 11():1173. PubMed ID: 32655512 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]